Home Category Region Publishers About Us Contact Us
Japanese Korean Chinese
Home > Market Research Report > Pharmaceutical > Generic Drugs > Emerging Generic Pharmaceuticals Markets in Europe
Category
Pharmaceutical (4989)
Bone Disease Treatment (46)
Cancer (883)
Diabetes (159)
Drug Delivery System (184)
Drug Discovery (1403)
Generic Drugs (128)
Infectious Disease (406)
Mental Disease (98)
Neurodegenerative Disease (180)
Obesity Treatment (49)
OTC Drug (149)
Pharmaceutical Companies (562)
Prescription Drugs (120)
Regulation (122)
Vaccines (178)
Veterinary Medicine (28)
Market Research Report

Emerging Generic Pharmaceuticals Markets in Europe

Published by Frost & Sullivan
Published December, 2008 Product code 91118
Content info 75 Pages
Price
US $ 6000 Web Access (Regional License)
US $ 6500 Hard Copy & Web Access (Regional License)


Emerging Generic Pharmaceuticals Markets in Europe published by Frost & Sullivan in December, 2008. This report consists of 75 Pages and the price starts from US $ 6000.

Introduction

Abstract

This research service analyses and provides growth opportunities in the Emerging Generics Pharmaceuticals Market in Europe. It analyses market drivers, restraints and challenges faced by industry participants. Revenue forecasts has been discussed. It also provides strategic recommendations.

Table of Contents

1. EXECUTIVE SUMMARY

Overview

  • Summary of the Emerging European Generic Pharmaceuticals Market

2. GLOSSARY OF TERMS

List of Terms

  • Abbreviations

3. RESEARCH METHODOLOGY

Research Scope and Objective

  • Methodology

4. INTRODUCTION

Overview

  • Introduction
  • Regulatory Issues

European Bolar Clause

  • Bolar Clause

Reference Pricing System

  • Overview

Trends in the European Generics Market

  • Trends
  • Pricing and Reimbursement

5. EMERGING GENERIC PHARMACEUTICALS MARKET IN EUROPE

Emerging Generic Pharmaceuticals Market in Europe

  • Overview

Industry Challenges in the Emerging Generic Pharmaceuticals Market in Europe

  • Challenges

Market Drivers for the Emerging Generic Market in Europe

  • Market Drivers

Market Restraints for the Emerging Generic Market in Europe

  • Market Restraints

6. GENERIC PHARMACEUTICALS MARKET IN ITALY

Overview

  • Generic Pharmaceuticals Market in Italy

Market Engineering Measurements Analysis

  • Market Engineering Measurements for the Italian Generic Pharmaceuticals Market

Revenue Forecasts for the Generic Pharmaceuticals Market in Italy

  • Forecasts for the Italian Generic Pharmaceuticals Market

7. GENERIC PHARMACEUTICALS MARKET IN SPAIN

Overview

  • Generic Pharmaceuticals Market in Spain

Market Engineering Measurements Analysis

  • Market Engineering Measurements for the Spanish Generic Pharmaceuticals Market

Revenue Forecasts for the Generic Pharmaceuticals Market in Spain

  • Forecasts for the Spanish Generic Pharmaceuticals Market

8. GENERIC PHARMACEUTICALS MARKET IN FRANCE

Overview

  • Generic Pharmaceuticals Market in France

Market Engineering Measurements Analysis

  • Market Engineering Measurements for the French Generic Pharmaceuticals Market

Revenue Forecasts for the Generic Pharmaceuticals Market in France

  • Forecasts for the French Generic Pharmaceuticals Market

9. GENERIC PHARMACEUTICALS MARKET IN PORTUGAL

Overview

  • Generic Pharmaceuticals Market in Portugal

Market Engineering Measurements Analysis

  • Market Engineering Measurements for the Portugal Generic Pharmaceuticals Market

Revenue Forecasts for the Generic Pharmaceuticals Market in Portugal

  • Forecasts for the Portugal Generic Pharmaceuticals Market

10. STRATEGIC ANALYSIS AND RECOMMENDATIONS

Strategic Recommendation

  • Recommendations for the European Emerging Generics Market
  • Country-wise Recommendations for Emerging Generics Markets

11. DATABASE OF KEY INDUSTRY PARTICIPANTS

Key Industry Participants

  • List of Key Industry Participants

12. DECISION SUPPORT DATABASES

Healthcare Expenditure

  • Total Healthcare Expenditure
  • Government Healthcare Expenditure
  • Private Healthcare Expenditure
  • Total Population
  • Pharmaceutical R&D Expenditure
Back to Top